- Home
- MDXG vs BST Comparison
MDXG vs BST Comparison
Compare MDXG & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BST
- Stock Information
- Founded
- MDXG 2006
- BST 2014
- Country
- MDXG United States
- BST United States
- Employees
- MDXG N/A
- BST N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BST Finance Companies
- Sector
- MDXG Health Care
- BST Finance
- Exchange
- MDXG Nasdaq
- BST Nasdaq
- Market Cap
- MDXG 1.1B
- BST 1.2B
- IPO Year
- MDXG N/A
- BST N/A
- Fundamental
- Price
- MDXG $9.24
- BST $36.42
- Analyst Decision
- MDXG Strong Buy
- BST
- Analyst Count
- MDXG 5
- BST 0
- Target Price
- MDXG $12.00
- BST N/A
- AVG Volume (30 Days)
- MDXG 1.2M
- BST 105.9K
- Earning Date
- MDXG 10-30-2024
- BST 01-01-0001
- Dividend Yield
- MDXG N/A
- BST 8.18%
- EPS Growth
- MDXG N/A
- BST N/A
- EPS
- MDXG 0.52
- BST N/A
- Revenue
- MDXG $342,804,000.00
- BST N/A
- Revenue This Year
- MDXG $9.56
- BST N/A
- Revenue Next Year
- MDXG $9.19
- BST N/A
- P/E Ratio
- MDXG $18.28
- BST N/A
- Revenue Growth
- MDXG 10.93
- BST N/A
- 52 Week Low
- MDXG $5.47
- BST $29.62
- 52 Week High
- MDXG $9.49
- BST $37.96
- Technical
- Relative Strength Index (RSI)
- MDXG 81.04
- BST 50.32
- Support Level
- MDXG $8.55
- BST $35.42
- Resistance Level
- MDXG $9.49
- BST $36.69
- Average True Range (ATR)
- MDXG 0.40
- BST 0.48
- MACD
- MDXG 0.15
- BST -0.07
- Stochastic Oscillator
- MDXG 96.72
- BST 40.45
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.